Mym Nutraceuticals Inc (MYM.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
(Values in thousands)
| 05-2020 | 05-2019 | 05-2018 | 05-2017 | 05-2016 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 487 | 395 | 84 | 0 | 3 |
| Accounts receivable | 279 | 920 | -1,246 | -121 | 95 |
| Accounts payable and accrued liabilities | -569 | 40 | 694 | N/A | N/A |
| Other Working Capital | 308 | 866 | -3,036 | -158 | 139 |
| Other Operating Activity | -6,951 | -9,483 | -3,488 | -392 | -302 |
| Operating Cash Flow | $-6,447 | $-7,262 | $-6,992 | $-671 | $-65 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -63 | -6,447 | -4,381 | -36 | 762 |
| Net Acquisitions | -250 | 0 | N/A | N/A | N/A |
| Purchase Of Investment | N/A | N/A | -287 | N/A | N/A |
| Purchase Sale Intangibles | 0 | -151 | -297 | -6 | N/A |
| Other Investing Activity | 22 | -315 | -1,684 | 0 | -191 |
| Investing Cash Flow | $-291 | $-6,914 | $-6,648 | $-41 | $571 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 0 | -165 | -480 |
| Debt Issued | 2,600 | N/A | N/A | N/A | N/A |
| Debt Repayment | -2,786 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 5,555 | 8,634 | 15,199 | 1,249 | 171 |
| Other Financing Activity | -226 | 1,237 | 4,525 | 31 | -73 |
| Financing Cash Flow | $5,144 | $9,871 | $19,723 | $1,115 | $-383 |
| Beginning Cash Position | 2,327 | 6,631 | 549 | 145 | 22 |
| End Cash Position | 732 | 2,327 | 6,631 | 549 | 145 |
| Net Cash Flow | $-1,595 | $-4,304 | $6,083 | $403 | $123 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,447 | -7,262 | -6,992 | -671 | -65 |
| Capital Expenditure | -71 | -6,598 | -4,678 | -41 | N/A |
| Free Cash Flow | -6,517 | -13,860 | -11,670 | -712 | -65 |